RNA interference suppression of Nogo-66 receptor prevents Nogo-66-mediated inhibition of invasion and adhesion and simultaneously increases cell apoptosis in C6 cells

Oncology Reports

Volumn 30, Issue 5, 2013, Pages 2171-2178

  Tong, Song ^a   Xiong, Nanxiang ^a   Shen, Jianying ^b  

^a UNION HOSPITAL   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

C6 cell line; Metastasis; Nogo 66 receptor; Nogo A; RNA interference

Indexed keywords

NOGO 66 RECEPTOR; PROTEIN NOGO 66; PROTEIN NOGO A; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE REPRESSION; GENE SILENCING; GLIOMA CELL; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; RNA INTERFERENCE;

APOPTOSIS; BRAIN NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; GPI-LINKED PROTEINS; HUMANS; MYELIN PROTEINS; NEOPLASM INVASIVENESS; RECEPTORS, CELL SURFACE; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 84885068645     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2694     Document Type: Article

References (21)

1. Chen MS, Huber AB, van der Haar ME, Frank M, Schnell L, Spillmann AA, Christ F and Schwab ME: Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 403: 434-439, 2000.
2. Fournier AE, GrandPre T and Strittmatter SM: Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature 409: 341-346, 2001.
3. Liao H, Duka T, Teng FY, Sun L, Bu WY, Ahmed S, Tang BL and Xiao ZC: Nogo-66 and myelin-associated glycoprotein (MAG) inhibit the adhesion and migration of Nogo-66 receptor expressing human glioma cells. J Neurochem 90: 1156-1162, 2004.
4. Xiong N, Shen J, Li S, Li J and Zhao H: Expression of Nogo-66 receptor in human astrocytoma is correlated with tumor malignancy. Mol Biol Rep 39: 2625-2632, 2012.
5. Kilic E, ElAli A, Kilic U, Guo Z, Ugur M, Uslu U, Bassetti CL, Schwab ME and Hermann DM: Role of Nogo-A in neuronal survival in the reperfused ischemic brain. J Cereb Blood Flow Metab 30: 969-984, 2010.
6. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM and McEwan RN: A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47: 3239-3245, 1987.
7. Kawajiri H, Yashiro M, Shinto O, Nakamura K, Tendo M, Takemura S, Node M, Hamashima Y, Kajimoto T, Sawada T, et al: A novel transforming growth factor beta receptor kinase inhibitor, A-77, prevents the peritoneal dissemination of scirrhous gastric carcinoma. Clin Cancer Res 14: 2850-2860, 2008.
8. Nishimura S, Chung YS, Yashiro M, Inoue T and Sowa M: Role of alpha 2 beta 1- and alpha 3 beta 1-integrin in the peritoneal implantation of scirrhous gastric carcinoma. Br J Cancer 74: 1406-1412, 1996.
9. Dasari VR, Velpula KK, Kaur K, Fassett D, Klopfenstein JD, Dinh DH, Gujrati M and Rao JS: Cord blood stem cell-mediated induction of apoptosis in glioma downregulates X-linked inhibitor of apoptosis protein (XIAP). PLoS One 5: e11813, 2010.
10. Friedlander DR, Zagzag D, Shiff B, Cohen H, Allen JC, Kelly PJ and Grumet M: Migration of brain tumor cells on extracellular matrix proteins in vitro correlates with tumor type and grade and involves alphaV and beta1 integrins. Cancer Res 56: 1939-1947, 1996.
11. Yang HW, Menon LG, Black PM, Carroll RS and Johnson MD: SNAI2/Slug promotes growth and invasion in human gliomas. BMC Cancer 10: 301, 2010.
12. Eroglu C: The role of astrocyte-secreted matricellular proteins in central nervous system development and function. J Cell Commun Signal 3: 167-176, 2009.
13. Irintchev A, Rollenhagen A, Troncoso E, Kiss JZ and Schachner M: Structural and functional aberrations in the cerebral cortex of tenascin-C deficient mice. Cereb Cortex 15: 950-962, 2005.
14. Giese A, Loo MA, Rief MD, Tran N and Berens ME: Substrates for astrocytoma invasion. Neurosurgery 37: 294-302, 1995.
15. Giese A, Rief MD, Loo MA and Berens ME: Determinants of human astrocytoma migration. Cancer Res 54: 3897-3904, 1994.
16. Amberger VR, Hensel T, Ogata N and Schwab ME: Spreading and migration of human glioma and rat C6 cells on central nervous system myelin in vitro is correlated with tumor malignancy and involves a metalloproteolytic activity. Cancer Res 58: 149-158, 1998.
17. Matsushita S, Nitanda T, Furukawa T, Sumizawa T, Tani A, Nishimoto K, Akiba S, Miyadera K, Fukushima M, Yamada Y, et al: The effect of a thymidine phosphorylase inhibitor on angiogenesis and apoptosis in tumors. Cancer Res 59: 1911-1916, 1999.
18. Ghobrial IM, Witzig TE and Adjei AA: Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin 55: 178-194, 2005.
19. Rossi L, De Martino A, Marchese E, Piccirilli S, Rotilio G and Ciriolo MR: Neurodegeneration in the animal model of Menkes' disease involves Bcl-2-linked apoptosis. Neuroscience 103: 181-188, 2001.
20. Hengartner MO: The biochemistry of apoptosis. Nature 407: 770-776, 2000.
21. Yan J, Zhou X, Guo JJ, Mao L, Wang YJ, Sun J, Sun LX, Zhang LY, Zhou XF and Liao H: Nogo-66 inhibits adhesion and migration of microglia via GTPase Rho pathway in vitro. J Neurochem 120: 721-731, 2012.